ENSC · Ensysce Biosciences, Inc. · Executive Compensation
$0.52
0.00 (-0.62%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. While the Company believes in the viability of its strategy to ultimately realize revenues and in its ability to raise additional funds, management cannot be certain that additional funding will be available on acceptable terms, or at all. The Company's ability to continue as a going concern is dependent upon its ability to obtain adequate financing and achieve profitable operations. As a result, these plans do not alleviate substantial doubt about the Company's ability to continue as a going concern for a period of 12 months following the date these consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$10.12M
Shares
19.46M
Volume · Oct 21
294.04K
Avg daily vol (3M)
13.76M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Lynn Kirkpatrick | Chief Executive Officer | $442,392 |
| Dr. Lynn Kirkpatrick | Chief Executive Officer | $442,392 |
| Dave Humphrey | Chief Financial Officer | $371,267 |
| Geoff Birkett | Chief Commercial Officer | $343,634 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Dr. Lynn Kirkpatrick | Chief Executive Officer | $508,575 |
| Lynn Kirkpatrick | Chief Executive Officer | $508,575 |
| Dave Humphrey | ChiefFinancial Officer | $441,950 |
| Geoff Birkett | Chief Commercial Officer | $392,354 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dave Humphrey | ChiefFinancial Officer | $780,617 |
| Dr. Lynn Kirkpatrick | Chief Executive Officer | $622,609 |
| Lynn Kirkpatrick | Chief Executive Officer | $622,609 |
| Geoff Birkett | Chief Commercial Officer | $366,956 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Lynn Kirkpatrick | Chief Executive Officer | $288,149 |
| Dr. Lynn Kirkpatrick | Chief Executive Officer | $288,149 |
| Geoff Birkett | Chief Commercial Officer | $135,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dr. Lynn Kirkpatrick | Chief Executive Officer | $155,868 |
| Lynn Kirkpatrick | Chief Executive Officer | $155,868 |
| Richard Wright | Chief Business Officer | $76,000 |
| Geoff Birkett | Chief Commercial Officer | $72,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James Morrison | director | Appointed | 2026-08-06 |
| James Morrison | President | Appointed | 2026-08-06 |
| Lynn Kirkpatrick | President | Resigned | 2026-08-06 |
| Jeffrey Millard | Chief Operating Officer | Resigned | 2026-07-15 |
| Curtis Rosebraugh | member of our Board of Directors | Resigned | 2026-04-03 |
| Lee Rauch | member of our Board of Directors | Resigned | 2026-03-30 |
| Dr. William K. Schmidt | interim Chief Medical Officer | Appointed | 2022-09-16 |
| Dr. Nily Osman | Chief Medical Officer | Resigned | 2022-09-16 |
Leadership
- Lynn Kirkpatrick CEO, Board Member
- Bob Gower Chairman, Board Member
- David Humphrey CFO
- Adam Levin Board Member
- Adam S. Levin Board Member
- Andrew Benton Board Member
- Dr. Lynn Kirkpatrick Board Member
- James Morrison Board Member
- Steve R. Martin Board Member
- William Chang Board Member